doi:10.1186/s12889-023-17325-9...
BioMed Central
Epidemiology
2023
12/20/2023
Introduction Evidence on the willingness of men who have sex with men (MSM) with oral pre-exposure prophylaxis (PrEP) experience, especially those with suboptimal adherence, to take long-acting injectable PrEP (LAI-PrEP) is critical to guide future LAI-PrEP implementation.
Objective The objective was to assess the willingness of MSM with oral PrEP experience to take LAI-PrEP.
Methods MSM who participated in the China Real-world Study of Oral PrEP (CROPrEP) were enrolled in this study.
Information on the willingness of MSM to take LAI-PrEP and potential correlates was collected using a structured online questionnaire.
The main outcomes were the willingness of MSM to take LAI-PrEP and its association with HIV-related behaviours, sexually transmitted infections, and oral PrEP history.
Logistic regression was used to identify correlates of the willingness of MSM to take LAI-PrEP.
Results A total of 612 former CROPrEP participants (FCPs) were included in this study.
There were 315 (51.5%) daily oral PrEP (D-PrEP) users and 297 (48.5%) event-driven oral PrEP (ED-PrEP) users at the last follow-up.
Most FCPs (77.8%) were willing to take free LAI-PrEP.
FCPs with no less than two sexual male partners (aOR = 1.54, [95% CI: 1.04, 2.29], P = 0.031), those with male partners with unknown HIV statuses (aOR = 2.04, [95% CI: 1.31, 3.18], P = 0.002), those with recreational drug use (aOR = 1.58, [95% CI: 1.05, 2.40], P = 0.030), and those with HSV-2 positivity (aOR = 2.15, [95% CI: 1.30, 3.57], P = 0.003) were more willing to take LAI-PrEP, while ED-PrEP users (aOR = 0.66, [95% CI: 0.45, 0.98], P = 0.037) and FCPs with suboptimal oral PrEP adherence (aOR = 0.58, [95% CI: 0.36, 0.94], P = 0.026) were less willing to take LAI-PrEP.
Conclusion LAI-PrEP has good prospects for expanding PrEP coverage.
However, FCPs with suboptimal oral PrEP adherence are less likely to take LAI-PrEP.
Further intervention and implementation efforts are needed to improve the willingness of MSM to use LAI-PrEP, and sexual health should be considered during the discussion about PrEP initiation.
Liu, Yingjie,Chu, Zhenxing,Wang, Hongyi,Huang, XiaoJie,Chen, YaoKai,Wang, Hui,Zou, Dehua,Jiang, YongJun,Geng, WenQing,Hu, Qinghai,Zhou, Baosen,Shang, Hong, 2023, Willingness to take long-acting injectable pre-exposure prophylaxis among men who have sex with men who participated in the CROPrEP study: a cross-sectional online study, BioMed Central